Smartleaf Asset Management LLC Raises Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Smartleaf Asset Management LLC raised its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 108.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,275 shares of the company’s stock after buying an additional 3,779 shares during the period. Smartleaf Asset Management LLC’s holdings in Privia Health Group were worth $142,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Park Avenue Securities LLC boosted its holdings in shares of Privia Health Group by 3.8% during the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock worth $287,000 after purchasing an additional 532 shares during the period. First Horizon Advisors Inc. raised its position in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after purchasing an additional 632 shares during the last quarter. KBC Group NV lifted its holdings in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after buying an additional 871 shares during the period. US Bancorp DE grew its position in shares of Privia Health Group by 6.7% in the 4th quarter. US Bancorp DE now owns 18,058 shares of the company’s stock worth $353,000 after buying an additional 1,134 shares during the last quarter. Finally, Fifth Third Bancorp increased its stake in shares of Privia Health Group by 38.3% during the fourth quarter. Fifth Third Bancorp now owns 5,105 shares of the company’s stock valued at $100,000 after buying an additional 1,415 shares during the period. Institutional investors own 94.48% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Needham & Company LLC lifted their price target on shares of Privia Health Group from $25.00 to $30.00 and gave the company a “buy” rating in a report on Friday, February 28th. Macquarie began coverage on shares of Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price on the stock. JPMorgan Chase & Co. increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research note on Friday, November 29th. Barclays upped their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Finally, Truist Financial raised their target price on Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus price target of $26.47.

Privia Health Group Price Performance

PRVA opened at $25.26 on Friday. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.04. The stock has a 50-day moving average price of $22.83 and a 200-day moving average price of $20.75. The firm has a market cap of $3.04 billion, a PE ratio of 252.63, a P/E/G ratio of 3.47 and a beta of 0.85.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.